Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

21.52 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 12.53.500.5360000000126.57612.3750.3790.3790.380.3790.3790.3790.380.3790.3790.3790.380.3790.3790.3791.1930.3050.3050.3050.3050.3050.3050.3050.3050.3050.017001.20000000
Cost of Revenue 0.00244.3370.0030.2680.0030.1520.1130.1150.1080.110.1210.1210000.0010000000000000000000000000.60.6000000
Gross Profit 12.498-40.837-0.0030.268-0.003-0.152-0.113-0.115-0.108-0.11-0.121126.45512.3750.3790.3790.3790.3790.3790.3790.380.3790.3790.3790.380.3790.3790.3791.1930.3050.3050.3050.3050.3050.3050.3050.3050.3050.017000.6-0.6000000
Gross Profit Ratio 1-11.66800.500000000.9991110.9971111111111111111111111000.50000000
Reseach & Development Expenses 70.97148.65256.48955.12639.08734.76434.05431.84126.90129.73430.02223.925.60616.87121.8715.52214.40810.9439.5629.5029.92312.2911.27915.82114.09514.85115.33916.59912.1889.8629.5528.47412.2746.1314.7862.5872.9682.2711.7231.4551.7094.8742.1371.0590.8450.7310.5730.001
General & Administrative Expenses 029.06123.02244.14317.26814.91411.96110.1928.247.996.8366.9276.8015.8425.6724.7185.8246.0465.9175.0833.6053.4633.9113.8924.1254.4794.7914.0833.5634.2853.932.9723.2692.8084.2722.3973.1953.2882.7111.8346.0271.451.8461.821.4391.3660.7380
Selling & Marketing Expenses 000-21.36400000000000000000000000000000000000000000000
SG&A 31.10629.06123.02222.77917.26814.91411.96110.1928.247.996.8366.9276.8015.8425.6724.7185.8246.0465.9175.0833.6053.4633.9113.8924.1254.4794.7914.0833.5634.2853.932.9723.2692.8084.2722.3973.1953.2882.7111.8346.0271.451.8461.821.4391.3660.7380
Other Expenses 0-0.086-0.087-0.055-0.066-0.0934.8892.839-0.295-0.0310.1160.449-0.041-0.05-0.057-0.563-0.584-0.039-0.020.205-0.075-0.0430.5090.4960.0150.104-0.1220.385-0.053-0.087-0.0530.3260.2690.276-0.0180.01-0.037-0.004-0.0060000-0.914-1.612-0.6430.1550
Operating Expenses 102.07777.71379.51177.90556.35549.67846.01542.03335.14137.72436.85830.82732.40722.71327.54220.2420.23216.98915.47914.58513.52815.75315.1919.71318.2219.3320.1320.68215.75114.14713.48211.44615.5438.9399.0584.9846.1635.5594.4343.2897.7366.3243.9832.8792.2842.0971.3110.001
Operating Income -89.577-74.216-79.514-77.905-56.355-49.678-46.015-42.033-35.141-37.724-36.85895.749-20.032-22.334-27.163-19.86-19.853-16.61-15.1-14.205-13.149-15.374-14.811-19.333-17.841-18.951-19.751-19.489-15.446-13.842-13.177-11.141-15.238-8.634-8.753-4.679-5.858-5.542-4.434-3.289-7.736-6.324-3.983-2.879-2.284-2.097-1.311-0.001
Operating Income Ratio -7.166-21.2050-145.34500000000.756-1.619-58.929-71.67-52.263-52.383-43.826-39.842-37.382-34.694-40.565-39.079-50.876-47.074-50.003-52.113-16.336-50.643-45.384-43.203-36.528-49.961-28.308-28.698-15.341-19.207-32600-6.4470000000
Total Other Income Expenses Net 5.4516.1537.114-0.0555.209-0.0934.8892.839-0.262-0.031-0.3110.449-0.041-0.05-0.057-0.563-0.584-0.039-0.020.205-0.075-0.0430.5090.4960.0150.104-0.1220.385-0.053-0.087-0.0530.3260.2690.276-1.721-0.06-1.644-0.35-0.1380.006-0.0071.835-0.041-1.404-2.479-1.5780.632-0.002
Income Before Tax -84.126-68.063-72.4-72.473-51.146-44.615-41.126-39.194-35.403-37.572-37.16996.198-20.639-22.91-27.723-20.423-20.437-17.062-15.236-14-12.829-14.916-14.302-18.837-17.338-18.388-19.398-19.104-15.088-13.639-12.971-10.815-14.969-8.358-10.33-5.263-7.731-6.214-4.911-3.548-7.772-4.488-4.02-4.327-4.894-3.813-1.137-0.003
Income Before Tax Ratio -6.73-19.4470-135.21100000000.76-1.668-60.449-73.148-53.745-53.923-45.018-40.201-36.842-33.85-39.356-37.736-49.571-45.747-48.517-51.182-16.013-49.469-44.718-42.528-35.459-49.079-27.403-33.869-17.256-25.348-365.52900-6.4770000000
Income Tax Expense -0.0020-0.044.993-0.003-0.058-4.932-2.8850.2620.6640.311-0.010.6080.5840.566-0.021-0.0230.5990.429-0.446-0.395-0.2770.18-0.36-0.343-0.384-0.4130.157-0.411-0.29-0.259-0.1010.069-0.0041.559-1.4372.0930.6680.4710.2630.036-1.8360.0370.5340.9981.073-0.0190
Net Income -84.126-68.063-72.4-72.473-51.146-44.615-36.194-36.309-35.665-37.572-37.4896.198-20.639-22.91-27.723-20.423-20.437-17.062-15.236-14-12.829-14.916-14.302-18.837-17.338-18.388-19.398-19.104-15.088-13.639-12.971-10.815-14.969-8.358-10.33-5.263-7.731-6.214-4.911-3.548-7.772-4.488-4.02-4.327-4.894-3.813-1.137-0.003
Net Income Ratio -6.73-19.4470-135.21100000000.76-1.668-60.449-73.148-53.745-53.923-45.018-40.201-36.842-33.85-39.356-37.736-49.571-45.747-48.517-51.182-16.013-49.469-44.718-42.528-35.459-49.079-27.403-33.869-17.256-25.348-365.52900-6.4770000000
EPS -0.98-0.8-0.85-1-0.73-0.64-0.52-0.57-0.59-0.62-0.641.81-0.4-0.44-0.54-0.44-0.46-0.42-0.44-0.44-0.41-0.47-0.53-0.7-0.68-0.74-0.79-0.8-0.68-0.7-0.71-0.59-0.84-0.47-2.27-0.79-1.16-0.94-0.74-0.53-1.17-0.046-0.042-0.045-0.051-0.039-0.012-67.42
EPS Diluted -0.98-0.8-0.85-1-0.73-0.64-0.52-0.57-0.59-0.62-0.641.81-0.4-0.44-0.54-0.44-0.46-0.42-0.44-0.44-0.41-0.47-0.53-0.7-0.68-0.74-0.79-0.8-0.68-0.7-0.71-0.59-0.84-0.47-2.27-0.79-1.16-0.94-0.74-0.53-1.17-0.046-0.042-0.045-0.051-0.039-0.012-66.91
EBITDA -89.577-74.213-79.511-72.407-56.355-44.577-46.015-42.033-33.647-36.866-36.50795.749-19.982-22.267-27.084-19.86-19.853-16.402-14.764-14.205-13.099-15.374-14.811-19.333-17.841-18.951-19.751-19.489-15.292-13.769-13.171-11.141-15.238-8.634-6.997-6.629-4.251-5.025-4.206-3.287-7.725-8.156-3.938-2.385-1.416-1.16-1.782-0.001
EBITDA Ratio -7.166-21.2040-135.08800000000.756-1.615-58.752-71.462-52.263-52.383-43.277-38.955-37.382-34.562-40.565-39.079-50.876-47.074-50.003-52.113-16.336-50.138-45.144-43.184-36.528-49.961-28.308-22.941-21.734-13.938-295.58800-6.4380000000